Capricor Therapeutics, Inc. (CAPR)
NASDAQ · Healthcare
$19.50+0.31%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $983.37M
- P/E ratio
- —
- EPS
- —
- Volume
- 1,649,759
- 52-week high
- —
- 52-week low
- —
- Open
- $19.68
- Day high
- $20.17
- Day low
- $18.93
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $0 | -$105.04M | -$2.26 |
| 2024 | $22.27M | -$40.47M | -$1.15 |
| 2023 | $25.18M | -$22.29M | -$0.83 |
| 2022 | $2.55M | -$29.02M | -$1.18 |
| 2021 | $244.9K | -$20.02M | -$0.87 |
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
- CEO
- Linda Marbán
- Employees
- 231
- Country
- US
- IPO date
- Feb 13, 2007
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Capricor Therapeutics, Inc.'s stock price today?
- CAPR is trading at $19.50 as of Jul 20, 2026.
- What is Capricor Therapeutics, Inc.'s market cap?
- Capricor Therapeutics, Inc. (CAPR) has a market capitalization of $983.37M.
- Does Capricor Therapeutics, Inc. pay a dividend?
- Capricor Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Capricor Therapeutics, Inc. in?
- Capricor Therapeutics, Inc. operates in the Healthcare sector.